Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

EHU089621

Sigma-Aldrich

MISSION® esiRNA

targeting human FOXP4

Sign Into View Organizational & Contract Pricing

Select a Size

All Photos(1)

Select a Size

Change View

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TCATTCCCAGATGGTCTCGTGCACCCCCCGACCTCGGCCGCAGCCCCTGTCACCCCTCTACGGCCCCCTGGCCTGGGCTCTGCCTCCCTGCATGGTGGGGGCCCAGCCCGTCGGAGAAGCAGTGACAAGTTCTGCTCCCCCATCTCCTCAGAGCTGGCCCAGAATCATGAGTTCTACAAGAACGCCGACGTCCGGCCCCCCTTCACCTACGCCTCCCTCATCCGCCAGGCCATCCTGGAAACCCCTGACAGGCAGCTGACCCTGAATGAGATCTATAACTGGTTCACCAGGATGTTCGCCTATTTCCGCAGAAACACTGCCACCTGGAAGAACGCCGTGCGCCACAACCTCAGCCTGCACAAGTGCTTCGTCCGCGTGGAGAACGTCAAGGGTGCCGTGTGGACTGTGGACGAGCGGGAGTATCAGAA

Ensembl | human accession no.

ENSG00000137166

NCBI accession no.

NM_138457

shipped in

ambient

storage temp.

−20°C

Gene Information

human ... FOXP4(116113), FOXP4(116113)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
QCS
DOR

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Xiaoli Wang et al.
OncoTargets and therapy, 13, 4569-4579 (2020-06-18)
Laryngeal cancer is a common malignant tumor in the ENT, of which laryngeal squamous cell carcinoma (LSCC) accounts for more than 90% of laryngeal cancer. The purpose of this study is to investigate the regulatory mechanism of lncRNA SNHG16 in
Tao Ma et al.
Cancer management and research, 11, 2783-2793 (2019-05-02)
Family of forkhead box transcription factors has been found to play key roles in multiple types of cancer. Our study is to decipher the effects of FOXP4 in human breast cancer (BC). Quantitative real-time polymerase chain reaction and Western blot

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service